Arcoma AB Statistics

Total Valuation

Arcoma AB has a market cap or net worth of SEK 123.94 million. The enterprise value is 115.75 million.

Market Cap	123.94M
Enterprise Value	115.75M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Arcoma AB has 13.19 million shares outstanding. The number of shares has decreased by -0.24% in one year.

Current Share Class	13.19M
Shares Outstanding	13.19M
Shares Change (YoY)	-0.24%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.77%
Owned by Institutions (%)	13.81%
Float	7.17M

Valuation Ratios

The trailing PE ratio is 12.87 and the forward PE ratio is 10.65.

PE Ratio	12.87
Forward PE	10.65
PS Ratio	0.85
PB Ratio	2.02
P/TBV Ratio	2.02
P/FCF Ratio	n/a
P/OCF Ratio	10.84
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	12.02
EV / Sales	0.80
EV / EBITDA	9.23
EV / EBIT	9.81
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	1.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	57.25

Financial Efficiency

Return on equity (ROE) is 16.86% and return on invested capital (ROIC) is 12.62%.

Return on Equity (ROE)	16.86%
Return on Assets (ROA)	7.85%
Return on Invested Capital (ROIC)	12.62%
Return on Capital Employed (ROCE)	19.22%
Revenue Per Employee	4.84M
Profits Per Employee	320,967
Employee Count	31
Asset Turnover	1.55
Inventory Turnover	2.85

Taxes

In the past 12 months, Arcoma AB has paid 2.22 million in taxes.

Income Tax	2.22M
Effective Tax Rate	18.73%

Stock Price Statistics

The stock price has decreased by -44.05% in the last 52 weeks. The beta is 0.70, so Arcoma AB's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-44.05%
50-Day Moving Average	9.30
200-Day Moving Average	11.13
Relative Strength Index (RSI)	44.80
Average Volume (20 Days)	12,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Arcoma AB had revenue of SEK 145.22 million and earned 9.63 million in profits. Earnings per share was 0.73.

Revenue	145.22M
Gross Profit	60.07M
Operating Income	11.79M
Pretax Income	11.85M
Net Income	9.63M
EBITDA	12.54M
EBIT	11.79M
Earnings Per Share (EPS)	0.73

Full Income Statement

Balance Sheet

The company has 8.20 million in cash and n/a in debt, giving a net cash position of 8.20 million or 0.62 per share.

Cash & Cash Equivalents	8.20M
Total Debt	n/a
Net Cash	8.20M
Net Cash Per Share	0.62
Equity (Book Value)	61.38M
Book Value Per Share	4.66
Working Capital	38.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	11.43M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 41.36%, with operating and profit margins of 8.12% and 6.63%.

Gross Margin	41.36%
Operating Margin	8.12%
Pretax Margin	8.16%
Profit Margin	6.63%
EBITDA Margin	8.63%
EBIT Margin	8.12%
FCF Margin	n/a

Dividends & Yields

Arcoma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.24%
Shareholder Yield	n/a
Earnings Yield	7.77%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6